Skip to main content

RWD Pandemonium During a Pandemic: Lessons for Future RWE Generation and Decision Making?

Program Commitee:

Helga Gardarsdottir, Utrecht University, Utrecht, the Netherlands & University of Iceland, Reykjavik, Iceland, Chair
Larus S Gudmundsson, University of Iceland, Reykjavik, Iceland
Freyja Jonsdottir, University of Iceland, Reykjavik, Iceland & Landspitali University Hospital, Reykjavík, Iceland
Martin Ingi Sigurdsson, University of Iceland, Reykjavik, Iceland & Landspitali University Hospital, Reykjavík, Iceland
Andrew Bate, GSK, United Kingdom
Maurizio Sessa, University of Copenhagen, Copenhagen, Denmark
Miyuki Hsing-Chun Hsieh, ISPE Student Council Co-Chair
Claire Huang, ISPE Student Council Co-Chair
Judith Maro, ISPE Education Committee Co-Chair
Debbie Layton, ISPE Educational Committee Co-Chair
James Vrac, ISPE Executive Secretary
Jennifer Lanphere, ISPE Staff
Christine Morgan, ISPE Staff

Sunday April 23, 2023

7:00-5:00pm Registration
8:30-12:30pm Introduction to Pharmacoepidemiology
8:30-12:30pm 2023 Scientific Program Committee Meeting
12:30-1:30pm Lunch
1:30-5:30pm Advanced Pharmacoepidemiology
5:30-7:00pm Welcome Reception

Monday April 24, 2023

8:00-9:00am Exhibits/Poster viewing
8:00-5:00pm Registration
9:00-9:15am Welcome and Introductions (ISPE President/ISPE MY Chair Sci committee)
9:15-11:00am  Plenary Session I: Real time use of real world data for decision making
  The COVID-19 pandemic triggered an unprecedent push towards high need for generation and use of real world data to support timely decisions. This session will provide insights into clinical and policy drive decision making at the national and international level.

Moderators: Lárus S. Guðmundsson, associate professor, University of Iceland

9:15-9:45: Disseminating Covid19 science: the Iceland experience
Martin Ingi Sigurdsson, Professor of Anesthesiology and Critical Care Medicine, University of Iceland

9:45-10:15: Contact Tracing in Covid-19: Data and Digitization
Guðrún Aspelund, Chief Epidemiologist, Icelandic Directorare of Health

10:15-10:45: Value of real world data for decision making at the European level
Menno van der Elst, EMA Pharmacovigilance Risk Assessment Commitee (PRAC) member, Dutch Medicines Evaluation Board.

10:45-11:00: Discussion
11:00-11:30am Coffee break/Exhibit/Poster Viewing
11:30-1:15pm Plenary Session II: Pandemic driven (real world) data shifts
  The pandemic has impacted our lifes in various ways during the past years. The impact on healthcare can be traced through the health care data that was generated during this time. In this session we will showcase what this means for us as pharmacoepidemiologists and our future studies that rely on use of health care data.

Helga Gardarsdottir, associate professor, Utrecht University & University of Iceland

Impact of COVID-19 pandemic on health care seeking behaviour, real-world data capture, and nonrandomized real-world evidence studies
Anne Mobley Butler, Assistant Professor, Washington University in St. Louis, USA

Ways COVID-19 may impact unrelated pharmacoepidemiologic research
Michael Webster-Clark, post-doctoral fellow, McGill University, Canada

The changing landscape of Nordic pharmacoepidemiology during the COVID-19 pandemic and prospects for the post-pandemic period
Morten Andersen, professor, Copenhagen University, Denmark 


1:15-2:15pm Lunch break/Exhibit/Poster Viewing
2:15-3:45pm Student Oral Session I
3:45-4:15pm Coffee break/Exhibit/Poster Viewing
4:15-5:45pm Student Oral Session II
5:45-6:00pm Closing Remarks
6:30-7:30pm Student/Early Career Professionals Meet & Greet

Tuesday April 25, 2023

8:00-9:00am Exhibits/Poster viewing
8:00-5:00pm Registration

Plenary Session III: Real-world data for precision medicine: a pharmacoepidemiological perspective


The COVID-19 pandemic has pushed forward research on tailor treatment and interventions to unique individual or population-level traits complementing conventional pharmacoepidemiological approaches. In this session, we will showcase precision medicine and precision public health approaches used for pharmacoepidemiological safety and effectiveness surveillance.

Maurizio Sessa, assistant professor, University of Copenhagen, Denmark Genomics & precision medicine SIG chair

Use of postapproval data for real time personalized safety monitoring
Andrew Bate, Vice president, Head of Safety Innovation & Analytics, GSK

09:30-10:00: Safety monitoring in general practice: insights from Iceland on benzodiazepine’ and opioids’ risk
Larus S Gudmundsson, associate professor, University of Iceland

10:00-10:30: Precision Medicine using real-world data: a focus on cardiovascular therapy.
David O Arnar, Professor of Cardiology, University of Iceland

10:45-11:15am Coffee break/Exhibit/Poster Viewing
11:15-1:00pm Plenary Session IV: Future innovation and outlook for the field of pharmacoepidemiology
  The pandemic has and is acting as a stimulus for innovation right across the field of pharmacoepidemiology. In what areas are we seeing most impetus? A range of different stakeholders will share their perspective on the changes that are and need to occur as Pharmacoepdiemiology advances.

Andrew Bate, Vice president, Head of Safety Innovation & Analytics, GSK
Susana Perez-Gutthan, Vice President, Global Head Epidemiology, RTI International

The regulatory perspective
Alison Cave, PhD, Chief Safety Officer, MHRA

The academic perspective
Robbert Platt, PhD, Professor, McGill University (CNODES)

The industry perspective
Jamie Geier, Global Head, Quantitative Safety & Epidemiology, Novartis


1:00-2:00pm Lunch break/Exhibit/Poster Viewing
2:00-3:30pm Student Oral Session III
3:30-4:00pm Coffee break/Exhibit/Poster Viewing
4:00-5:30pm Student Oral Session IV
5:30-5:45pm Closing Remarks & Adjournment

Schedule as of 12.13.22
*all times in GMT